""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_orig"	"response_agent"	"proterm_and_extra"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"publication_reference_url"	"subObsID"	"uniqObsID"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"
"role"	""	""	""	"tissue"	"background"	"cell_biomarker"	"background"	"background"	"measured"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"reference"	"background"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type PRO &extra terms"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year"	"exposure material"	""	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"Anderson et al. (2019) Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans. PMID: <a href = \"https://www.ncbi.nlm.nih.gov/pubmed/?term=29535712\">29535712</a>"	"ID of observation within its submission"	"Uniq ID of observation within submission type"
""	"20190321-hipciof_ctf_29535712"	"2019.03.21"	"hipciof_ctf_33"	"peripheral blood mononuclear cell"	"NK cells CD3- CD56dim"	"natural killer cell"	"& CD56+-"	"cell type frequency"	"up"	""	"14"	"days"	"Human immunodeficiency virus"	""	"CN54gp140 adjuvanted with GLA-AF"	"VO_0000295"	""	"14d-0hr"	"time of vaccination (first dose)"	"Adults (18-45)"	"29535712"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/"	"1"	"153"
